| Item Type | Name |
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Base Sequence
|
|
Concept
|
DNA Damage
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Carbonic Anhydrases
|
|
Concept
|
Cell Division
|
|
Concept
|
Cell Separation
|
|
Concept
|
Genetic Vectors
|
|
Concept
|
Imidazoles
|
|
Concept
|
Dexamethasone
|
|
Concept
|
Dendritic Cells
|
|
Concept
|
Chemotaxis, Leukocyte
|
|
Concept
|
Kidney Neoplasms
|
|
Concept
|
Drug Evaluation, Preclinical
|
|
Concept
|
Fibrinogen
|
|
Concept
|
Fibroblasts
|
|
Concept
|
Enzyme Activation
|
|
Concept
|
Genetic Engineering
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
|
Concept
|
Hydroxamic Acids
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Gene Amplification
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Macrophages
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Mice, Inbred BALB C
|
|
Concept
|
Mice, Inbred C57BL
|
|
Concept
|
Mutation
|
|
Concept
|
Ovarian Neoplasms
|
|
Concept
|
Lipopolysaccharides
|
|
Concept
|
NAD
|
|
Concept
|
Genes, ras
|
|
Concept
|
Humans
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Tomography, X-Ray Computed
|
|
Concept
|
Genetic Variation
|
|
Concept
|
Protein Engineering
|
|
Concept
|
Vaccination
|
|
Concept
|
Histocompatibility Antigens Class I
|
|
Concept
|
Transduction, Genetic
|
|
Concept
|
Herpesvirus 1, Human
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Th1 Cells
|
|
Concept
|
Cell Culture Techniques
|
|
Concept
|
Drug Resistance, Neoplasm
|
|
Concept
|
Antibodies, Blocking
|
|
Concept
|
Caspases
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Mitogen-Activated Protein Kinases
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Cell Adhesion Molecules
|
|
Concept
|
Up-Regulation
|
|
Concept
|
Cryopreservation
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Sequence Analysis, DNA
|
|
Concept
|
Mesentery
|
|
Concept
|
Genes, Reporter
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
MAP Kinase Kinase 1
|
|
Concept
|
Mice, Knockout
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Antigens, CD34
|
|
Concept
|
ras Proteins
|
|
Concept
|
Th2 Cells
|
|
Concept
|
Staurosporine
|
|
Concept
|
Cancer Vaccines
|
|
Concept
|
Genes, T-Cell Receptor
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Lab-On-A-Chip Devices
|
|
Concept
|
Single-Cell Analysis
|
|
Concept
|
Exome
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Clonal Evolution
|
|
Concept
|
Positron-Emission Tomography
|
|
Concept
|
bcl-2-Associated X Protein
|
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
|
Concept
|
Proto-Oncogene Proteins B-raf
|
|
Concept
|
Indoleamine-Pyrrole 2,3,-Dioxygenase
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
Antineoplastic Protocols
|
|
Concept
|
bcl-X Protein
|
|
Concept
|
Mice
|
|
Concept
|
Caspase 8
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Chemokine CCL1
|
|
Concept
|
HEK293 Cells
|
|
Concept
|
Natural Killer T-Cells
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
CTLA-4 Antigen
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Monitoring, Immunologic
|
|
Concept
|
PTEN Phosphohydrolase
|
|
Concept
|
DNA Copy Number Variations
|
|
Concept
|
Genetic Therapy
|
|
Concept
|
Interleukin-17
|
|
Concept
|
Hematologic Neoplasms
|
|
Concept
|
Histone Deacetylase Inhibitors
|
|
Concept
|
Phosphatidylinositol 3-Kinases
|
|
Concept
|
K562 Cells
|
|
Concept
|
Genes, Transgenic, Suicide
|
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
Granzymes
|
|
Concept
|
NK Cell Lectin-Like Receptor Subfamily A
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Lectins, C-Type
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
T Cell Transcription Factor 1
|
|
Concept
|
MART-1 Antigen
|
|
Concept
|
Antibodies
|
|
Concept
|
Cell Line
|
|
Concept
|
Cell Survival
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Keloid
|
|
Concept
|
Kinetics
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Lymphocytes
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Gene Expression Regulation, Neoplastic
|
|
Concept
|
Immunophenotyping
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Cytokines
|
|
Concept
|
Gelsolin
|
|
Concept
|
Coculture Techniques
|
|
Concept
|
Computational Biology
|
|
Concept
|
Complementarity Determining Regions
|
|
Concept
|
MicroRNAs
|
|
Concept
|
Intracellular Space
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Caspase 9
|
|
Academic Article
|
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.
|
|
Academic Article
|
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
|
|
Academic Article
|
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
|
|
Academic Article
|
Active Immunotherapy of Cancer.
|
|
Academic Article
|
CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
|
|
Academic Article
|
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
|
|
Academic Article
|
Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance.
|
|
Academic Article
|
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.
|
|
Academic Article
|
The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
|
|
Academic Article
|
Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
|
|
Academic Article
|
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells.
|
|
Academic Article
|
Identification of a novel gelsolin truncate in the vertical and metastatic phase malignant melanomas.
|
|
Academic Article
|
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
|
|
Academic Article
|
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
|
|
Academic Article
|
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.
|
|
Academic Article
|
Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.
|
|
Academic Article
|
A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.
|
|
Academic Article
|
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
|
|
Academic Article
|
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
|
|
Academic Article
|
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.
|
|
Academic Article
|
Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies.
|
|
Academic Article
|
The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy.
|
|
Academic Article
|
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.
|
|
Academic Article
|
Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.
|
|
Academic Article
|
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
|
|
Academic Article
|
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
|
|
Academic Article
|
PD-1 Blockade Expands Intratumoral Memory T Cells.
|
|
Academic Article
|
Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid.
|
|
Academic Article
|
Natural killer T cells in advanced melanoma patients treated with tremelimumab.
|
|
Academic Article
|
Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.
|
|
Academic Article
|
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.
|
|
Academic Article
|
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
|
|
Academic Article
|
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
|
|
Academic Article
|
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
|
|
Academic Article
|
Correction to: Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.
|
|
Concept
|
Carbonic Anhydrase IX
|
|
Academic Article
|
Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
|
|
Academic Article
|
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401.
|